Quant Healthcare Fund Regular vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹402 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.39 |
| Manager | Rohan Korde | Sanjeev Sharma |
| ISIN Code | INF00XX01BL5 | INF966L01CG3 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | 2.13% | 1.13% |
| 6 Month | 2.73% | 5.13% |
| 1 Year | -4.07% | -6.29% |
| 3 Year | 18.84% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | -1.46% | -0.03% |
| 1 Year | -1.88% | 3.89% |
| 3 Year | 15.66% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 18.94% | 11.19% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 15.64% | - |
| Sharp | 0.77% | - |
| Beta | 0.95% | - |
| Alpha | -2.74% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Rohan Korde | Sanjeev Sharma |
| Total AUM | ₹4626 Cr | ₹39731 Cr |
| Funds Managed | 10 | 22 |
| ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 3.56 | 32.28 |
| Large Cap | 29.45 | 9.19 |
| Mid Cap | 37.33 | 9.09 |
| Small Cap | 29.66 | 49.44 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 1.52 | 17.84 |
| Healthcare | 91.78 | 68.48 |
| Basic Materials | 3.67 | - |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | 5.94 |
| Consumer Defensive | - | 7.74 |
Top Comparisons
Kotak Liquid Regular Plan Growth
3Y Returns6.18%
Kotak Liquid Regular Plan Growth
3Y Returns6.18%
BANDHAN Infrastructure Fund - Regular Plan - Growth
3Y Returns26.67%
Canara Robeco Infrastructure Fund - Regular Plan - Growth Option
3Y Returns25.61%
SBI Short Horizon Debt Fund - Ultra Short Term Fund - Institutional Plan - Growth
3Y Returns7.13%
Baroda BNP Paribas Ultra Short Duration Fund - Regular Plan - Growth
3Y Returns7.3%
SBI ESG Exclusionary Strategy Fund- REGULAR PLAN - Growth
3Y Returns13.66%
Quant Quantamental Fund Regular - Growth
3Y Returns20.14%